BridgeMD
New treatment option for Intracerebral Hemorrhage
Official title International Care Bundle Evaluation in Cerebral Hemorrhage Research
ClinicalTrials.gov ID: NCT06429332
What this study is testing
- What it's testing
- Spontaneous intracerebral haemorrhage (ICH) accounts for approximately 10-15% of all strokes but stands for 50% of stroke-related morbidity and mortality. Approximately half of all patients with ICH have a decreased level of consciousness at hospital admission.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (age ≥18 years)
- Non-contrast computerized tomography (NCCT) imaging-verified diagnosis of spontaneous intracerebral haemorrhage
- ≤24 hours from symptom onset or presumed symptom onset (last seen well)
You likely can't join if
- Previous care limitation
- End-stage comorbidity with short life-expectancy (\<6 m; e.g. terminal cancer)
- ICH caused by brain tumor or cerebral venous thrombosis
- Clinical signs of brain herniation at first presentation (unresponsive patient with bilaterally fixed, maximally dilated pupils)
- Pregnant women beyond 22 weeks gestation may only be included after thorough discussion with an obstetrician to determine risks vs benefit.
The study team makes the final eligibility decision.
Where it's taking place
- Oklahoma City, Oklahoma, United States
- Adelaide, Australia
- Clayton, Australia
- Sydney, Australia
- Greater Sudbury, Ontario, Canada
- Hamilton, Ontario, Canada
- Ottawa, Ontario, Canada
- Hong Kong, Hong Kong
- Reykjavik, Iceland
- Avezzano, Italy
- Città di Castello, Italy
- Gubbio, Italy
- Perugia, Italy
- Roma, Italy
- Kuala Lumpur, Malaysia
- Serdang, Malaysia
- Eksjö, Sweden
- Gothenburg, Sweden
- Hässleholm, Sweden
- Helsingborg, Sweden
+ 27 more site(s).
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oklahoma City, Oklahoma, United States; Adelaide, Australia; Clayton, Australia; Sydney, Australia; Greater Sudbury, Ontario, Canada; Hamilton, Ontario, Canada and 41 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.